High yield expression in a recombinant E. coli of a codon optimized chicken anemia virus capsid protein VP1 useful for vaccine development

Microbial Cell Factories

Research

Meng-Shiunn Lee¹  You-Cheng Hseu²  Hsi-Jien Chen³  Yi-Yang Lien⁴  Guan-Hua Lai⁵  Min-Ying Wang⁵  Chi-Hung Huang⁶  Jung-Yie Kao⁷  Ming-Kuem Lin⁸  Bang-Jau You⁸  Meng-Shiou Lee⁸  Wen-Te Chang⁸  Wen- Hsin Lin⁹ 

[1] Department of Medical Research, Tung's Taichung MetroHarbor Hospital, Taichung, Taiwan;Dept. of Cosmeceutics, College of Pharmacy, China Medical University, Taichung, Taiwan;Dept. of Safety, Health and Environmental Engineering, Mingchi University of Technology, Taichung, Taiwan;Dept. of Veterinary Medicine, National Pingtung University of Science and Technology, Pingtung, Taiwan;Graduate Institute of Biotechnology, College of Agriculture and Natural Resources, National Chung Hsing University, Taichung, Taiwan;Graduate School of Biotechnology, Hung kuang University, Taichung, Taiwan;Institute of Biochemistry, College of Life Science, National Chung Hsing University, Taichung, Taiwan;School of Chinese Pharmaceutical Sciences and Chinese Medicine Resources, China Medical University, Taichung, Taiwan;School of Pharmacy Undergraduate Program, Master Degree Program, Ph.D Program, China Medical University, Taichung, Taiwan;

关键词: Codon Usage;    Subunit Vaccine;    IPTG Induction;    Rare Codon;    Chicken Anemia Virus;   

DOI  :  10.1186/1475-2859-10-56

 received in 2011-04-06, accepted in 2011-07-23,  发布年份 2011

来源: Springer

【 摘 要 】

BackgroundChicken anemia virus (CAV), the causative agent chicken anemia, is the only member of the genus Gyrovirus of the Circoviridae family. CAV is an immune suppressive virus and causes anemia, lymph organ atrophy and immunodeficiency. The production and biochemical characterization of VP1 protein and its use in a subunit vaccine or as part of a diagnostic kit would be useful to CAV infection prevention.ResultsSignificantly increased expression of the recombinant full-length VP1 capsid protein from chicken anemia virus was demonstrated using an E. coli expression system. The VP1 gene was cloned into various different expression vectors and then these were expressed in a number of different E. coli strains. The expression of CAV VP1 in E. coli was significantly increased when VP1 was fused with GST protein rather than a His-tag. By optimizing the various rare amino acid codons within the N-terminus of the VP1 protein, the expression level of the VP1 protein in E. coli BL21(DE3)-pLysS was further increased significantly. The highest protein expression level obtained was 17.5 g/L per liter of bacterial culture after induction with 0.1 mM IPTG for 2 h. After purification by GST affinity chromatography, the purified full-length VP1 protein produced in this way was demonstrated to have good antigenicity and was able to be recognized by CAV-positive chicken serum in an ELISA assay.ConclusionsPurified recombinant VP1 protein with the gene's codons optimized in the N-terminal region has potential as chimeric protein that, when expressed in E. coli, may be useful in the future for the development of subunit vaccines and diagnostic tests.

【 授权许可】

Unknown   
© Lee et al; licensee BioMed Central Ltd. 2011. This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.